Most interestingly, we observed a positive correlation between PRLHR methylation in our set of hippocampal samples and both principal AD neuropathological hallmarks, β-amyloid deposits (r = 0.385; p-value < 0.05), and p-tau burden (r = 0.457; p-value = 0.006). Here, MAPT is linked to Alzheimer disease.